These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 18062342

  • 1. [Chronic obstructive pulmonary disease. No increased survival with combination therapy].
    Ecker-Schlipf B.
    Med Monatsschr Pharm; 2007 Nov; 30(11):428-9. PubMed ID: 18062342
    [No Abstract] [Full Text] [Related]

  • 2. [Debates surrounding COPD].
    Tillie-Leblond I, Housset B.
    Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
    [No Abstract] [Full Text] [Related]

  • 3. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec; 17(98):229. PubMed ID: 19418648
    [Abstract] [Full Text] [Related]

  • 4. Treatment of chronic obstructive pulmonary disease: Combination or component therapy?
    Hackam DG.
    CMAJ; 2003 May 13; 168(10):1296-7. PubMed ID: 12743078
    [No Abstract] [Full Text] [Related]

  • 5. Prevention of death in COPD.
    La Vecchia C, Fabbri LM.
    N Engl J Med; 2007 May 24; 356(21):2211-2; author reply 2213-4. PubMed ID: 17526088
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of death in COPD.
    Kupfer Y, Tessler S.
    N Engl J Med; 2007 May 24; 356(21):2212-3; author reply 2213-4. PubMed ID: 17526086
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of death in COPD.
    Duerden M.
    N Engl J Med; 2007 May 24; 356(21):2212; author reply 2213-4. PubMed ID: 17526087
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of death in COPD.
    Barnes PJ.
    N Engl J Med; 2007 May 24; 356(21):2211; author reply 2213-4. PubMed ID: 17522406
    [No Abstract] [Full Text] [Related]

  • 9. [The MMW Drug Prize 2002: Prize for a new classic with innovation potential].
    Schultze-Werninghaus G.
    Med Klin (Munich); 2002 Dec 15; 97 Suppl 2():1. PubMed ID: 12593173
    [No Abstract] [Full Text] [Related]

  • 10. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec 15; 16(92):257-8. PubMed ID: 18092426
    [No Abstract] [Full Text] [Related]

  • 11. Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study.
    Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Yates JC, Jones PW.
    Clin Respir J; 2011 Jan 15; 5(1):44-9. PubMed ID: 21159140
    [Abstract] [Full Text] [Related]

  • 12. Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.
    Johnson M, Agusti AG, Barnes NC.
    COPD; 2008 Dec 15; 5(6):369-75. PubMed ID: 19353351
    [Abstract] [Full Text] [Related]

  • 13. [Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial].
    Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC, Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group.
    Rev Port Pneumol; 2005 Dec 15; 11(6):587-9. PubMed ID: 16514718
    [No Abstract] [Full Text] [Related]

  • 14. COPD: treatments benefit patients.
    Rennard SI.
    Lancet; 2003 Feb 08; 361(9356):444-5. PubMed ID: 12583937
    [No Abstract] [Full Text] [Related]

  • 15. The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
    Doherty DE, Chapman KR, Martinez FJ, Belfer MH.
    J Fam Pract; 2007 Oct 08; 56(10 Suppl Value):S1-24. PubMed ID: 17949606
    [No Abstract] [Full Text] [Related]

  • 16. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
    Calverley P.
    MMW Fortschr Med; 2003 Jun 12; 145(24):20. PubMed ID: 12866294
    [No Abstract] [Full Text] [Related]

  • 17. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
    Suissa S.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):322-3. PubMed ID: 18676961
    [No Abstract] [Full Text] [Related]

  • 18. [Physiopathology of COPD: choosing the right therapeutic targets].
    Devillier P.
    Rev Pneumol Clin; 2003 Apr 15; 59(2 Pt 2):S6-10. PubMed ID: 12966779
    [No Abstract] [Full Text] [Related]

  • 19. Combined salmeterol and fluticasone for COPD.
    Khamis RY, Rajakulasingam RK.
    Lancet; 2003 May 10; 361(9369):1652; author reply 1652-3. PubMed ID: 12747905
    [No Abstract] [Full Text] [Related]

  • 20. [Chronic bronchitis. Gold standard from the internet].
    MMW Fortschr Med; 2001 Jun 07; 143(23):47. PubMed ID: 11460425
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.